118 related articles for article (PubMed ID: 38165714)
1. Polydiacetylene/lipid-coated red-emissive silica nanorods for the sustained release and ameliorated anticancer efficacy of a Ru(arene) complex bearing piperlongumine natural product.
Ishaniya W; Sumithaa C; Subramani M; Karanath-Anilkumar A; Munuswamy-Ramanujam G; Madan Kumar A; Rajendran S; Ganeshpandian M
Dalton Trans; 2024 Jan; 53(4):1616-1629. PubMed ID: 38165714
[TBL] [Abstract][Full Text] [Related]
2. Design of an anticancer organoruthenium complex as the guest and polydiacetylene-coated fluorogenic nanocarrier as the host: engineering nanocarrier using ene-yne conjugation for sustained guest release, enhanced anticancer activity and reduced
Sumithaa C; Gajda-Morszewski P; Ishaniya W; Khamrang T; Velusamy M; Bhuvanesh N; Brindell M; Mazuryk O; Ganeshpandian M
Dalton Trans; 2024 Jan; 53(3):966-985. PubMed ID: 38054338
[TBL] [Abstract][Full Text] [Related]
3. Nanoencapsulation of Ru(
Sumithaa C; Manjunathan T; Mazuryk O; Peters S; Pillai RS; Brindell M; Gopinath P; Ganeshpandian M
ACS Appl Bio Mater; 2022 Jul; 5(7):3241-3256. PubMed ID: 35786838
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Optimization of Mesoporous Silica Nanoparticles for Ruthenium Polypyridyl Drug Delivery.
Harun SN; Ahmad H; Lim HN; Chia SL; Gill MR
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498795
[TBL] [Abstract][Full Text] [Related]
5.
Gopalakrishnan D; Saravanan S; Merckx R; Madan Kumar A; Khamrang T; Velusamy M; Vasanth K; Sunitha S; Hoogenboom R; Maji S; Ganeshpandian M
Dalton Trans; 2021 Jun; 50(23):8232-8242. PubMed ID: 34037018
[TBL] [Abstract][Full Text] [Related]
6. Diatom-like silica-protein nanocomposites for sustained drug delivery of ruthenium polypyridyl complexes.
Shi H; Lou J; Lin S; Wang Y; Hu Y; Zhang P; Liu Y; Zhang Q
J Inorg Biochem; 2021 Aug; 221():111489. PubMed ID: 34000586
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanorods for improved oral drug absorption.
Zheng N; Li J; Xu C; Xu L; Li S; Xu L
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1132-1140. PubMed ID: 28783976
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Polydopamine-Coated Mesoporous Silica Nanorods and Spheres for the Delivery of Hydrophilic and Hydrophobic Anticancer Drugs.
Pada AK; Desai D; Sun K; Prakirth Govardhanam N; Törnquist K; Zhang J; Rosenholm JM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336697
[TBL] [Abstract][Full Text] [Related]
9. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
[TBL] [Abstract][Full Text] [Related]
10. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
11. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
[TBL] [Abstract][Full Text] [Related]
12. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
13. Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy.
Amin MU; Ali S; Ali MY; Tariq I; Nasrullah U; Pinnapreddy SR; Wölk C; Bakowsky U; Brüßler J
Eur J Pharm Biopharm; 2021 Aug; 165():31-40. PubMed ID: 33962002
[TBL] [Abstract][Full Text] [Related]
14. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine.
Mondragón L; Mas N; Ferragud V; de la Torre C; Agostini A; Martínez-Máñez R; Sancenón F; Amorós P; Pérez-Payá E; Orzáez M
Chemistry; 2014 Apr; 20(18):5271-81. PubMed ID: 24700694
[TBL] [Abstract][Full Text] [Related]
16. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
[TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
18. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent spherical mesoporous silica nanoparticles loaded with emodin: Synthesis, cellular uptake and anticancer activity.
Jänicke P; Lennicke C; Meister A; Seliger B; Wessjohann LA; Kaluđerović GN
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111619. PubMed ID: 33321661
[TBL] [Abstract][Full Text] [Related]
20. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
Ma B; He L; You Y; Mo J; Chen T
Drug Deliv; 2018 Nov; 25(1):293-306. PubMed ID: 29334793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]